incretin mimetic agents glp 1 receptor agonists Incretins: How we got here, where we're at and what is coming next Letter: Association Between Incretin Mimetics
Description
Zhou B, Caudal A, Tang X, Chavez JD, McMillen TS, Keller A, et al
In type 2 diabetes trials (the SUSTAIN program), Ozempic produced an average weight loss of around 4.5 kg to 6.5 kg (roughly 10 to 14 lbs) over 52 weeks, depending on the dose
Abstract Obesity affects nearly one in six adults worldwide
where the stakes are high, and the consequences of failure are severe
UH: Investigation, Supervision, Writingreview and editing
